Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D
ANN ARBOR, MI, November 5, 2020 — Shovels hit the dirt yesterday as Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters on 1180 East Ellsworth Road in Ann Arbor, MI. This new 66,000 square foot, three-story structure will house Cayman’s contract services, production, and research activities and will provide common areas including a gym and a company-wide meeting space that can be adapted to accommodate a more spacious and flexible working environment. Employees should occupy the new building by the end 2021.
Dr. Kirk Maxey, President and CEO of Cayman, at the site of the new R&D facility.
“It’s incredible to look back to the beginning when we opened 40 years ago with just a handful of people. Through the years, we’ve expanded into several separate buildings and have reached the point where we’ve outgrown some of these spaces and are ready to pull staff together under the same roof with more direct communication and personal interactions,” said Dr. Kirk Maxey, president and CEO at Cayman.
Nearly 300 people work at Cayman’s headquarters in Ann Arbor, including over 150 onsite scientists. Each new working space on Cayman’s now five-building campus brings opportunities to sustain company growth with the addition of new expertise, equipment, and product innovations. “Cayman dedicated more resources to our existing antiviral program when the COVID virus emerged early this year, bringing in new products to help support research in this novel area and establishing a strong new customer base,” said Dr. Michael Pisano, VP of Business Development and Contract Services. “To accommodate this demand, we continue to hire new staff and look forward to the new opportunities this state-of-the-art facility will provide to advance our research and development.”
Cayman has continued to grow over the past 40 years while helping to supply scientists worldwide with affordable, high-quality products and services necessary for advancing human and animal health and remains committed to serving the global research community from its home in Ann Arbor.
About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, we offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.